We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study– few concerns.
- Authors
Balan, Divya; Shetty, Manish R; Mohan, Manu K
- Abstract
This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL reversibility benchmarks and Concerns about incorporating a combination medication that includes an inhaled corticosteroid, inhaled corticosteroids are not typically associated with bronchodilation.
- Subjects
NON-smokers; OBESITY; SALMETEROL; FLUTICASONE; ALBUTEROL
- Publication
BMC Pulmonary Medicine, 2024, Vol 24, Issue 1, p1
- ISSN
1471-2466
- Publication type
Article
- DOI
10.1186/s12890-024-02951-9